E. Alidjinou

M. Buti, M. Honda, Hwai I. Yang, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro.

D. Hober, E. Alidjinou, M. Hamze, 2017, International journal of antimicrobial agents.

Repeated viral meningitis in a newborn

D. Hober, I. Schuffenecker, E. Alidjinou, 2020, Journal of NeuroVirology.

Effect of Coxsackievirus B4 Infection on the Thymus: Elucidating Its Role in the Pathogenesis of Type 1 Diabetes

D. Hober, E. Alidjinou, V. Geenen, 2021, Microorganisms.

Fighting Enteroviral Infections to Prevent Type 1 Diabetes

D. Hober, E. Alidjinou, F. Sane, 2022, Microorganisms.

Combating coxsackievirus B infections

D. Hober, E. Alidjinou, F. Sane, 2022, Reviews in medical virology.

Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases

D. Hober, K. Faure, E. Alidjinou, 2021, Infection.

Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy

D. Hober, G. Arunkumar, S. Aswathyraj, 2016, Medical Microbiology and Immunology.

Respiratory virus detection in returning travelers and pilgrims from the Middle East

D. Hober, K. Faure, E. Alidjinou, 2022, Travel medicine and infectious disease.

Enhancing and neutralizing anti‐coxsackievirus activities in serum samples from patients prior to development of type 1 diabetes

J. Ilonen, M. Knip, J. Toppari, 2020, Diabetes/metabolism research and reviews.

Coxsackievirus-B4E2 can infect monocytes and macrophages in vitro and in vivo.

D. Hober, E. Alidjinou, R. Desailloud, 2018, Virology.

Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells.

D. Hober, E. Alidjinou, I. Engelmann, 2013, Journal of molecular biology.

Severe encephalitis in a previously healthy teenager: who is the real culprit?

D. Hober, E. Alidjinou, R. Caumes, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance

D. Hober, E. Alidjinou, I. Engelmann, 2021, Journal of Infection.

Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl

D. Hober, E. Alidjinou, I. Engelmann, 2018, Pediatrics.

The role of the surface ligand on the performance of electrochemical SARS-CoV-2 antigen biosensors

R. Boukherroub, D. Devos, C. Cambillau, 2021, Analytical and Bioanalytical Chemistry.

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice

J. Dubuisson, D. Hober, S. Belouzard, 2021, bioRxiv.

Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology

J. Dubuisson, D. Hober, S. Belouzard, 2021 .

miRNAs in enterovirus infection

D. Hober, E. Alidjinou, I. Engelmann, 2018, Critical reviews in microbiology.

Detection of hepatitis B virus infection markers in dried plasma spots among patients in Congo-Brazzaville.

D. Hober, E. Alidjinou, F. Sane, 2014, Diagnostic microbiology and infectious disease.

Sanger sequencing versus INNO-LiPA® HBV PreCore assay for routine detection of precore and basal core promoter mutations in hepatitis virus B chronically infected patients.

D. Hober, E. Alidjinou, V. Canva, 2017, Diagnostic microbiology and infectious disease.

Viruses and Endocrine Diseases

D. Hober, E. Alidjinou, F. Sane, 2023, Microorganisms.

Infection à coxsackievirus B4, inflammation et persistance

E. Alidjinou, E. K. Alidjinou, 2016 .

Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People

A. Duhamel, A. Dendooven, D. Deplanque, 2021, Frontiers in Immunology.

Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection

A. Duhamel, A. Dendooven, D. Deplanque, 2021, bioRxiv.

Preanalytical Issues and Cycle Threshold Values in SARS-CoV-2 Real-Time RT-PCR Testing: Should Test Results Include These?

R. Boukherroub, D. Devos, C. Cambillau, 2021, ACS omega.

Enteroviruses in blood of patients with type 1 diabetes detected by integrated cell culture and reverse transcription quantitative real-time PCR

D. Hober, E. Alidjinou, M. Vantyghem, 2017, Acta Diabetologica.

Quantification of viral DNA during HIV-1 infection: A review of relevant clinical uses and laboratory methods.

D. Hober, E. Alidjinou, L. Bocket, 2015, Pathologie-biologie.

Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation

I. Fournier, D. Hober, E. Alidjinou, 2021, Microorganisms.

Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells

A. Yessoufou, K. Moutairou, D. Hober, 2020, Microorganisms.

Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity

A. Yessoufou, K. Moutairou, D. Hober, 2019, Cellular and Molecular Life Sciences.

Paediatric Enterovirus Meningitis without Cerebrospinal Fluid Pleocytosis.

D. Hober, E. Alidjinou, I. Engelmann, 2019, The Journal of infection.

Enteroviruses and Type 1 Diabetes Mellitus: An Overlooked Relationship in Some Regions

D. Hober, E. Alidjinou, I. Engelmann, 2020, Microorganisms.

The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients

I. Yakoub-Agha, K. Faure, E. Alidjinou, 2022, Blood advances.

Persistent viral DNA detection in blood after primary herpes simplex 1 infection revealed by hepatitis with hemophagocytic syndrome.

D. Hober, E. Alidjinou, I. Engelmann, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes

D. Hober, E. Alidjinou, C. Villenet, 2017, Virulence.

Monocytes of Patients with Type 1 Diabetes Harbour Enterovirus RNA

J. Weill, D. Hober, E. Alidjinou, 2015, European journal of clinical investigation.

Necessity to critically review the automatic results of the Xpert Flu assay

D. Hober, E. Alidjinou, I. Engelmann, 2017, Diagnostic Microbiology and Infectious Disease.

The history of plasma viral load and CD4 count impacts the size of HIV-1 reservoir.

É. Drumez, D. Hober, E. Alidjinou, 2017, The Journal of infection.

Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.

D. Hober, E. Alidjinou, O. Robineau, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Microelimination or not? The changing epidemiology of HIV-HCV coinfection in France 2012-2018.

C. Charpentier, R. Tubiana, C. Katlama, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of two commercial quantitative PCR assays for EBV DNA detection and their correlation with the first WHO International Standard for EBV

A. Duhamel, D. Hober, E. Alidjinou, 2018, Journal of medical microbiology.

Comparison of two commercial quantitative PCR assays and correlation with the first WHO International Standard for human CMV.

E. Chazard, D. Hober, E. Alidjinou, 2018, Diagnostic microbiology and infectious disease.

Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes.

D. Hober, E. Alidjinou, V. Geenen, 2014, Discovery medicine.

Enteroviral pathogenesis of type 1 diabetes: queries and answers.

D. Hober, E. Alidjinou, 2013, Current opinion in infectious diseases.

Enteroviral pathogenesis of type 1 diabetes: queries and answers

D. Hober, E. Alidjinou, 2013, Discovery medicine.

Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response

S. Susen, A. Duhamel, A. Dendooven, 2020, Clinical & translational immunology.

A real-time quantitative PCR targeting the viral vector for the monitoring of patients treated with axicabtagene ciloleucel.

I. Yakoub-Agha, D. Hober, E. Alidjinou, 2020, The Journal of molecular diagnostics : JMD.

Secondary syphilis in a 14-month-old girl and child-to-mother transmission

D. Hober, E. Alidjinou, B. Catteau, 2023, IDCases.

[Gardnerella vaginalis bacteremia in a male patient].

G. Dewulf, E. Alidjinou, E. Mazars, 2013, Medecine et maladies infectieuses.

A patient with fever, abdominal pain and bicytopenia: Trouble once again with these IgM antibodies!

D. Hober, E. Alidjinou, I. Engelmann, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Evaluation of the reverse transcription strand invasion based amplification (RT-SIBA) RSV assay, a rapid molecular assay for the detection of respiratory syncytial virus.

D. Hober, E. Alidjinou, M. Mäki, 2019, Diagnostic microbiology and infectious disease.

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2, and cellular immune responses 3 months after booster vaccination

B. Autran, Y. Yazdanpanah, A. Dendooven, 2022, Clinical Microbiology and Infection.

Cervical samples dried on filter paper and dried vaginal tampons can be useful to investigate the circulation of high-risk HPV in Congo.

D. Hober, E. Alidjinou, D Hober, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.

E. Alidjinou, P. Choisy, O. Robineau, 2020, AIDS patient care and STDs.

Routine drug resistance testing in proviral HIV‐1 DNA: Prevalence of stop codons and hypermutation, and associated factors

D. Hober, E. Alidjinou, O. Robineau, 2019, Journal of medical virology.

Sensing of COVID-19 spike protein in nasopharyngeal samples using a portable surface plasmon resonance diagnostic system

Ludovic S. Live, R. Boukherroub, D. Devos, 2022, Sensors & Diagnostics.

Enteroviruses and Type 1 Diabetes: Candidate Genes Linked With Innate Immune Response

D. Hober, E. Alidjinou, 2015, EBioMedicine.

A case of a non-immunocompromised adult with fever, mononucleosis and a serological puzzle.

A. Baras, D. Hober, E. Alidjinou, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Prospective Evaluation of a Commercial Dengue NS1 Antigen Rapid Diagnostic Test in New Caledonia

D. Hober, E. Alidjinou, A. Gourinat, 2022, Microorganisms.

Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping.

D. Hober, E. Alidjinou, O. Robineau, 2021, Journal of Antimicrobial Chemotherapy.

Resistance of Enteric Viruses on Fomites

D. Hober, P. Lobert, E. Alidjinou, 2017, Intervirology.

Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells

D. Hober, E. Alidjinou, C. Villenet, 2017, Cellular and Molecular Life Sciences.

Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19-directed CAR T-cell therapy in diffuse large B cell lymphoma.

I. Yakoub-Agha, E. Alidjinou, F. Morschhauser, 2023, British Journal of Haematology.

Oropharyngeal samples versus lesion specimens at diagnosis in patients infected with monkeypox virus in Northern France

D. Hober, E. Alidjinou, O. Robineau, 2022, Journal of medical virology.

Serum-derived IgG from coxsackievirus A6-infected patients can enhance the infection of peripheral blood mononuclear cells with coxsackievirus A6.

D. Hober, G. Arunkumar, S. Aswathyraj, 2018, Microbial pathogenesis.

Aqueous extracts of Syzygium brazzavillense can inhibit the infection with coxsackievirus B4 in vitro

D. Hober, E. Alidjinou, Etienne Nguimbi, 2019, Journal of medical virology.

Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo.

D. Hober, E. Alidjinou, R. Desailloud, 2018, Antiviral research.

Diabetes: Towards a coxsackievirus B-based vaccine to combat T1DM

D. Hober, E. Alidjinou, 2018, Nature Reviews Endocrinology.

Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine.

D. Hober, E. Alidjinou, F. Sane, 2015, Antiviral research.

Journal Pre-proof Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2, and cellular immune responses 3 months after booster vaccination

Yazdan, A. Dendooven, A. Goffard, 2022 .

Respiratory virus detection in returning travelers and pilgrims from the Middle East

D. Hober, K. Faure, E. Alidjinou, 2022, Travel medicine and infectious disease.